Speaker Spotlight – ‘Rohan Kamat’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

Speaker Spotlight – ‘Rohan Kamat’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

The 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 is just about 12 weeks away & we’re gleaming with excitement with what lies in store.  An opportunity to witness over 15+ industry experts delve deep into key topics such as cell culture & bioproduction, downstream processing & continuous biomanufacturing and cell and gene therapy analytics. A chance to network with 100+ peers from various domains within the bioprocessing ecosystem and 2 jam-packed days full of in-depth case studies & comprehensive presentations. As we count…

Read More

Speaker Spotlight – ‘Rachel Legmann ’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

Speaker Spotlight – ‘Rachel Legmann ’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

The 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 aims to delve deep into defining trends & innovation withing the bioprocessing ecosystem around major domains like cell culture & bioproduction, downstream processing & continuous biomanufacturing and cell and gene therapy analytics. Just under 12 weeks remain till we go LIVE in Boston with over 100+ attendees, in-depth case studies, various networking sessions & keynote presentations from 15+ leading industry experts. We’re tremendously excited to hear the speakers’ ideas, findings & foresight into the future….

Read More

Speaker Spotlight – ‘Joseph M. Roig’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

Speaker Spotlight – ‘Joseph M. Roig’ : 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference!

Boston plays host to the 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 and we’re literally counting down the days! With over 100+ attendees & in-depth case studies & keynote presentations from 15+ leading industry experts, the event promises to deliver a comprehensively enriching experience! As we keenly await to discover the speakers’ ideas, findings & foresight into the future of topics surrounding cell culture & bioproduction, downstream processing & continuous biomanufacturing and cell and gene therapy analytics, here’s a glimpse into what you…

Read More

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Read More

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK.   Q. What is the most trending areas of cellular therapies currently? ​ A. CART and NK cell Q. What are the recent developments and technological advancements?  A. CART for solid tumors and NK CAR  Q. What are the key take away points from your presentation? ​ A. They are basically summarized in my bullet points. I will…

Read More

Speaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

Speaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

London, December 13 – MarketsandMarkets interviewed Karin Jennbacken, Team Leader, Heart Failure in vitro team, AstraZeneca regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Dr Jennbacken’s team is responsible for target discovery and early development of therapeutics for treatment of patients with cardiovascular disease. Q. What is the most trending areas of cellular therapies currently? A. Cardiac therapies using pluripotent stem cells is where most of the researches are going on. Q. What are the…

Read More

Speaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

Speaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

London, December 13 – MarketsandMarkets interviewed Petter Björquist, CEO, Verigraft regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Petter Björquist is a PhD in Biology/Biochemistry from Gothenburg University, 50 + publications in peer reviewed journals, several book chapters and patents. Q. What is the most trending areas of cellular therapies currently? A. I would say that is 1) CAR T-cell Therapy. This field has exploded, and started a new era in cancer treatment. 2) Genome…

Read More